BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 2441105)

  • 1. Status of glomerular proteoglycans in aminonucleoside nephrosis.
    Lelongt B; Makino H; Kanwar YS
    Kidney Int; 1987 Jun; 31(6):1299-310. PubMed ID: 2441105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in proteoglycan metabolism in the nephrotic syndrome induced by the aminonucleoside of puromycin.
    Klein DJ; Dehnel PJ; Oegema TR; Brown DM
    Lab Invest; 1984 May; 50(5):543-51. PubMed ID: 6232422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of puromycin aminonucleoside on HSPG core protein content of glomerular epithelial cells.
    Kasinath BS; Singh AK; Kanwar YS; Lewis EJ
    Am J Physiol; 1988 Oct; 255(4 Pt 2):F590-6. PubMed ID: 2972214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in glomerular heparan sulfate in puromycin aminonucleoside nephrosis.
    Groggel GC; Hovingh P; Border WA; Linker A
    Am J Pathol; 1987 Sep; 128(3):521-7. PubMed ID: 2443012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unaltered anionic sites of glomerular basement membrane in aminonucleoside nephrosis.
    Kanwar YS; Jakubowski ML
    Kidney Int; 1984 Apr; 25(4):613-8. PubMed ID: 6482165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glomerular basement membrane heparan sulfate glycosaminoglycan in aminonucleoside of puromycin nephrosis.
    Garin EH; Shirey AJ
    Child Nephrol Urol; 1988-1989; 9(3):121-6. PubMed ID: 2978121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporation of 35sulfate into the glomerular basement membrane in puromycin aminonucleoside nephrosis.
    Garin EH; Boggs KP; Burke FC
    Int J Pediatr Nephrol; 1985; 6(2):117-20. PubMed ID: 4030221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of basement membrane component gene expression in glomeruli of aminonucleoside nephrosis.
    Nakamura T; Ebihara I; Shirato I; Tomino Y; Koide H
    Lab Invest; 1991 May; 64(5):640-7. PubMed ID: 2030578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of glomerular heparan-35SO4 proteoglycan by heparin from glomeruli of streptozocin-induced diabetic rats.
    Klein DJ; Oegema TR; Brown DM
    Diabetes; 1989 Jan; 38(1):130-9. PubMed ID: 2521210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo turnover of the basement membrane and other heparan sulfate proteoglycans of rat glomerulus.
    Beavan LA; Davies M; Couchman JR; Williams MA; Mason RM
    Arch Biochem Biophys; 1989 Mar; 269(2):576-85. PubMed ID: 2521995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerular proteoglycans in diabetes. Partial structural characterization and metabolism of de novo synthesized heparan-35SO4 and dermatan-35SO4 proteoglycans in streptozocin-induced diabetic rats.
    Klein DJ; Brown DM; Oegema TR
    Diabetes; 1986 Oct; 35(10):1130-42. PubMed ID: 2944782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anionic site and immunogold quantitation of heparan sulfate proteoglycans in glomerular basement membranes of puromycin aminonucleoside nephrotic rats.
    Rada JA; Carlson EC
    Anat Rec; 1991 Sep; 231(1):35-47. PubMed ID: 1750710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial characterization of heparan and dermatan sulfate proteoglycans synthesized by normal rat glomeruli.
    Klein DJ; Brown DM; Oegema TR
    J Biol Chem; 1986 Dec; 261(35):16636-52. PubMed ID: 2946688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of glomerular proteoglycans by insulin-like growth factor-1.
    Watanabe Y; Kashihara N; Makino H; Kanwar YS
    Kidney Int; 1992 May; 41(5):1262-73. PubMed ID: 1614040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosaminoglycans of the glomerular basement membrane in normal and nephrotic states.
    Kanwar YS; Rosenzweig LJ; Kerjaschki DI
    Ren Physiol; 1981; 4(2-3):121-30. PubMed ID: 7302362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered glomerular localization of heparan sulfate proteoglycan in experimental nephritides.
    Uchida M; Shibata N; Katoh M; Shigematsu H
    Acta Pathol Jpn; 1986 Jun; 36(6):827-38. PubMed ID: 2945356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
    Nakayama K; Natori Y; Sato T; Kimura T; Sugiura A; Sato H; Saito T; Ito S; Natori Y
    J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
    Grond J; Weening JJ; Elema JD
    Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution ultrastructural study of the rat glomerular basement membrane in aminonucleoside nephrosis.
    Inoue S; Bendayan M
    Ultrastruct Pathol; 1996; 20(5):409-16. PubMed ID: 8883324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin converting-enzyme inhibition restores glomerular glycosaminoglycans in rat puromycin nephrosis.
    Herman-Edelstein M; Chagnac A; Nevo Z; Skutelsky E; Evron Y; Hirsch Y; Ben-Dor L; Schwartz I; Schwartz D; Weinstein T
    Exp Toxicol Pathol; 2016 Nov; 68(10):543-552. PubMed ID: 27591087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.